Effects of omega-3 fatty acids supplement on antioxidant enzymes activity in type 2 diabetic patients

Iranian Journal of Public Health

Volumn 45, Issue 3, 2016, Pages 340-345

  Toorang, Fatemeh ^a   Djazayery, Abolghassem ^b   Djalali, Mahmoud ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant enzymes; Omega 3 supplement; Type 2 diabetes

Indexed keywords

EID: 84963811753     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bauer UE, Briss PA, Goodman RA, Bowman BA (2014). Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. The Lancet, 384 (9937): 45-52.
2. Yach D, Hawkes C, Gould CL, Hofman KJ (2004). The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA, 291(21): 2616-2622.
3. Nair SP, Shah N, Shah R (2012). Alteration in enzymatic antioxidant defense in diabetes mellitus. Biomed Res, 23 (3): 402-404.
4. Stephens JW, Khanolkar MP, Bain SC (2009). The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis, 202(2): 321-329.
5. Shaw JE, Sicree RA, Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Practice, 87(1): 4-14.
6. Carocho M, Ferreira IC (2013). A review on antioxidants, prooxidants and related controversy: Natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol, 51: 15-25.
7. Maritim A, Sanders R, Watkins RJ (2003). Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol, 17(1): 24-38.
8. Kuppusamy U, Indran M, Rokiah P (2005). Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients. Diabetic Med, 22 (10): 1343-1346.
9. Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE (2003). Fish and long-chain ω-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation, 107 (14): 1852-1857.
10. Carpentier YA, Portois L, Malaisse WJ (2006). n− 3 Fatty acids and the metabolic syndrome. AJCN, 83 (6): 1499S-1504S.
11. Zheng T, Zhao J, Wang Y, Liu W, Wang Z, Shang Y, Zhang W, Zhang Y, Zhong M (2014). The limited effect of omega-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: A meta-analysis. Clin Biochem, 47 (6): 369-377.
12. Poudyal H, Panchal SK, Diwan V, Brown L (2011). Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Progress Lipid Res, 50 (4): 372-387.
13. Shidfar F, Keshavarz A, Hosseyni S, Ameri A, Yarahmadi S (2008). Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients. East Mediterr Health J, 14 (2): 305-13.
14. Nettleton JA, Katz R (2005). n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc, 105 (3): 428-440.
15. Houshiarrad A, Esmaeili M (2012).Consumption pattern of edible fats and oils among households in Tehran 2020 National Nutrition And Food Technology Research Institute. Shahid Beheshti University Of Medical Sciences And Health Services (unpublished work).
16. Abei H (1984). Catalase invitro. Meth Enzymol, 105: 121-126.
17. Paglia DE, Valentine WN (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 70 (1): 158-169.
18. Goldberg D, Spooner R (1983). Glutathione reductase. Methods of enzymatic analysis, 3: 258-265.
19. Kusano C, Ferrari B (2008). Total antioxidant capacity: a biomarker in biomedical and nutritional studies. J Cell Mol Biol, 7: 1-15.
20. Toorang F, Djazayeri A, Jalali M, Eshraghian M, Farvid M, Pooya S (2008). The effect of supplementation with omega-3 fatty acids on HbA1c, total antioxidant capacity and superoxide dismutase and catalase activity in type 2 diabetic patients. Iran J Food Sci Tech, 3 (1): 1-8.
21. Mozaffarian D, Abdollahi M, Campos H, Houshiarrad A, Willett W (2007). Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr, 61(4): 1004-1010.
22. Fakher S, Djalali M, Tabei S, Zeraati H, Javadi E, Sadeghi M, Mostafavi E, Fatehi F (2007). Effect of vitamins A, E, C and Omega-3 fatty acids on lipid peroxidation in streptozotocin induced diabetic rats. Iran J Public Health, 36(2): 58-63.
23. Taheri E, Djalali M, Saedisomeolia A, Moghadam AM, Djazayeri A, Qorbani M (2012). The relationship between the activates of antioxidant enzymes in red blood cells and body mass index in Iranian type 2 diabetes and healthy subjects. J Diabetes Metab Disord, 11(1): 3-8.
24. Merzouk S, Hichami A, Madani S, Merzouk H, Berrouiguet A, Prost J, Moutairou K, Chabane-Sari N, Khan N (2003). Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen Physiol Biophys, 22 (1): 15-28.
25. Manco M, Calvani M, Mingrone G (2004). Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab, 6 (6): 402-413.
26. Sarbolouki S, Djalali M, Dorosty A, Djazayery S, Eshraghian M, Ebadi S, Hashemi S (2010). Effects of EPA and vitamin E on serum enzymatic antioxidants and peroxidation indices in patients with type II Diabetes Mellitus. Iran J Public Health, 39 (3): 82-91.
27. De Luis D, Conde R, Aller R, Izaola O, González Sagrado M, Perez Castrillón J, Dueñas A, Romero E (2009). Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. Eur Rev Med Pharmacol Sci, 13(1): 51-55.
28. Tricot S, Mimouni V, Rompion S, Froger C, Lacroix P, Roux S, Ulmann L (2010). No altered blood pressure and serum markers of oxidative stress after a long time dietary fish oil in the genetically 9 month-old type-2 diabetes Zucker rat. Prostaglandins Leukot Essent. Fatty Acids, 83(4): 211-218.
29. Ghiasvand R, Djalali M, Djazayery S, Keshavarz S, Hosseini M, Askari G, Jani N, Fardad N, Fatehi F (2010). Effect of Eicosapentaenoic Acid (EPA) and vitamin E on the blood levels of inflammatory markers, antioxidant enzymes, and lipid peroxidation in Iranian Basketball Players. Iran J Public Health, 39(1): 15–21.
30. Pooya S, Jalali MD, Jazayery AD, Saedisomeolia A, Eshraghian MR, Toorang F (2010). The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis, 20 (5): 326-331.